FRI0252 Summary of neutropenia in patients with rheumatoid arthritis treated with sirukumab in the sirround phase 3 clinical trials

T Takeuchi; Y Tanaka; M Schiff; M Harigai; K Brown; R Rao; K Fei; S Popik; K Yoshizawa; Q Wang; B Hsu

doi:10.1136/annrheumdis-2017-eular.6413

Article info

Poster Presentations

Rheumatoid arthritis - other biologic treatment

FRI0252 Summary of neutropenia in patients with rheumatoid arthritis treated with sirukumab in the sirround phase 3 clinical trials

Free

Authors

T Takeuchi 1Division of Rheumatology, Keio University School of Medicine, Tokyo PubMed articles Google scholar articles
Y Tanaka 2University of Occupational and Environmental Health, Kitakyushu, Japan PubMed articles Google scholar articles
M Schiff 3University of Colorado School of Medicine, Denver, CO, United States PubMed articles Google scholar articles
M Harigai 4Tokyo Women's Medical University, Shinjuku-ku, Tokyo, Japan PubMed articles Google scholar articles
K Brown 5GlaxoSmithKline, Collegeville, PA, United States PubMed articles Google scholar articles
R Rao 6GSK Medicines Research Centre, Hertfordshire, United Kingdom PubMed articles Google scholar articles
K Fei 7Janssen Research & Development, LLC, Spring House, PA, United States PubMed articles Google scholar articles
S Popik 7Janssen Research & Development, LLC, Spring House, PA, United States PubMed articles Google scholar articles
K Yoshizawa 8Janssen Pharm KK Japan, Chiyoda-ku, Tokyo, Japan PubMed articles Google scholar articles
Q Wang 7Janssen Research & Development, LLC, Spring House, PA, United States PubMed articles Google scholar articles
B Hsu 7Janssen Research & Development, LLC, Spring House, PA, United States PubMed articles Google scholar articles

Citation

Takeuchi T, Tanaka Y, Schiff M, et al

FRI0252 Summary of neutropenia in patients with rheumatoid arthritis treated with sirukumab in the sirround phase 3 clinical trials

Annals of the Rheumatic Diseases 2017;76:581.

Publication history

First published June 15, 2017.

Online issue publication

January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password